1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2:

Diffusion and perfusion results in patients <6 months from RTa

Treatment-Related Change (Median)Recurrent Tumor (Median)P ValueSurvival Analysis
HRP Value
ADCLesion0.001620.00139.001b5.563.047b
ADCROI0.00120.0011.1280.653.651
ADCRatio1.5851.482.2880.703.595
rCBVLesion0.881.76.028b1.382.233
rCBVROI1.6252.575.032b1.563.009b
PSRROI0.800.87.4670.166.040b
  • a ADC is reported in mm2/s; rCBV and PSR are unitless.

  • b Significant values.